Cardiovascular Diseases

US FDA grants 510(k) clearance to Motus GI’s Pure-Vu EVS System On February 15, 2022, The Pure-Vu® EVS System received 510(k) clearance from the US Food and Drug Administration, according to Motus GI Holdings, Inc., a medical technology company that provides endoscopy solutions that improve clinical outcomes and increase cost-efficiency in the diagnosis and management of gastrointestinal conditions. The new Pure-Vu EVS System is designed to speed up set-up, improve navigation in convoluted anatomy, expand on the Pure-Vu system's superior cleaning capabilities, and enable physicians to quickly overcome the obstacles of poorly prepared colons during a colonoscopy. ...